- Procter & Gamble Co (NYSE:PG) reported third-quarter FY22 sales growth of 7.1% year-on-year to $19.38 billion, beating the consensus of $18.73 billion.
- Organic sales increased 10%, driven by a 3% increase in shipment volume, 5% from improved pricing, and a 2% increase from geographic and product mix.
- Sales in the beauty segment rose 2%, the Grooming segment expanded 3%, and Health Care jumped 13%.
- Adjusted EPS of $1.33 beat the consensus of $1.30.
- Gross profit decreased 1% Y/Y to $9.1 billion. Gross margin decreased by 400 basis points to 46.7%.
- Operating margin contracted 10 basis points to 20.8%, while operating income for the quarter rose 6% to $4.02 billion.
- P&G held $8.5 billion in cash and equivalents as of March 31, 2022.
- Outlook: P&G raised FY22 all-in sales growth outlook to 4% - 5% (previously 3% - 4%).
- The company continues to expect FY22 core EPS growth of 3% - 6% versus FY21 Core EPS of $5.66.
- P&G also expects to pay over $8 billion in dividends and repurchase $10 billion of common shares in FY22.
- Price Action: PG shares are trading higher by 1.06% at $161.10 in premarket on the last check Wednesday.
Get all your news in one place.
100’s of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100’s of premium titles. One news app.
Procter & Gamble Q3 Earnings Top Estimates; Raises FY22 Top-Line Guidance
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member?
Sign in here
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Our Picks